These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1016 related items for PubMed ID: 24200925

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J, Piekarz J, Rydlewska A, Majewski J, Senderek T, Ząbek A, Małecka B.
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE).
    Healey JS, Hohnloser SH, Glikson M, Neuzner J, Mabo P, Vinolas X, Kautzner J, O'Hara G, VanErven L, Gadler F, Pogue J, Appl U, Gilkerson J, Pochet T, Stein KM, Merkely B, Chrolavicius S, Meeks B, Foldesi C, Thibault B, Connolly SJ, Shockless IMPLant Evaluation [SIMPLE] investigators.
    Lancet; 2015 Feb 28; 385(9970):785-91. PubMed ID: 25715991
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation.
    Fröhlich GM, Holzmeister J, Hübler M, Hübler S, Wolfrum M, Enseleit F, Seifert B, Hürlimann D, Lehmkuhl HB, Noll G, Steffel J, Falk V, Lüscher TF, Hetzer R, Ruschitzka F.
    Heart; 2013 Aug 28; 99(16):1158-65. PubMed ID: 23813845
    [Abstract] [Full Text] [Related]

  • 10. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry.
    Amit G, Suleiman M, Konstantino Y, Luria D, Kazatsker M, Chetboun I, Haim M, Gavrielov-Yusim N, Goldenberg I, Glikson M, Israeli Working Group on Pacing and Electrophysiology.
    Europace; 2014 Aug 28; 16(8):1175-80. PubMed ID: 24554524
    [Abstract] [Full Text] [Related]

  • 11. [Short-term and long-term outcome of left heart function after cardioverter defibrillator implantation].
    Takeichi K, Kasanuki H, Ohnishi S, Endoh Y, Hosoda S.
    J Cardiol; 1996 Nov 28; 28(5):277-86. PubMed ID: 8953401
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Patient, physician, and procedural factors influencing the use of defibrillation testing during initial implantable cardioverter defibrillator insertion: findings from the NCDR®.
    Russo AM, Wang Y, Al-Khatib SM, Curtis JP, Lampert R.
    Pacing Clin Electrophysiol; 2013 Dec 28; 36(12):1522-31. PubMed ID: 23981009
    [Abstract] [Full Text] [Related]

  • 14. Prophylactic implantable cardioverter defibrillators for primary prevention: From implantation to heart transplantation.
    Algalarrondo V, Perault R, Bories MC, Narayanan K, Garcia R, Combes N, Perier MC, Defaye P, Sadoul N, Gras D, Klug D, Bordachar P, Fauchier L, Deharo JC, Leclercq C, Boveda S, Marijon E, Babuty D, DAI-PP investigatorsParis Descartes University, 75006 Paris, France..
    Arch Cardiovasc Dis; 2018 Dec 28; 111(12):758-765. PubMed ID: 30078651
    [Abstract] [Full Text] [Related]

  • 15. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
    Kleemann T, Hochadel M, Strauss M, Skarlos A, Seidl K, Zahn R.
    J Cardiovasc Electrophysiol; 2012 Jul 28; 23(7):735-40. PubMed ID: 22313314
    [Abstract] [Full Text] [Related]

  • 16. Defibrillation testing during implantable cardioverter-defibrillator implantation in Italian current practice: the Assessment of Long-term Induction clinical ValuE (ALIVE) project.
    Stefano B, Pietro RR, Maurizio G, Maurizio L, Renato M, Maurizio L, Pietro R, Alessandro P, Gianluca B, Monica M, Sergio C, Massimo S.
    Am Heart J; 2011 Aug 28; 162(2):390-7. PubMed ID: 21835302
    [Abstract] [Full Text] [Related]

  • 17. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
    Healey JS, Hohnloser SH, Exner DV, Birnie DH, Parkash R, Connolly SJ, Krahn AD, Simpson CS, Thibault B, Basta M, Philippon F, Dorian P, Nair GM, Sivakumaran S, Yetisir E, Wells GA, Tang AS, RAFT Investigators.
    Circ Heart Fail; 2012 Sep 01; 5(5):566-70. PubMed ID: 22896584
    [Abstract] [Full Text] [Related]

  • 18. Intraoperative defibrillation threshold testing during implantable cardioverter-defibrillator insertion: do we really need it?
    Calvi V, Dugo D, Capodanno D, Arancio R, Di Grazia A, Liotta C, Puzzangara E, Ragusa A, Arestia A, Tamburino C.
    Am Heart J; 2010 Jan 01; 159(1):98-102. PubMed ID: 20102873
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.